305451 <common-name>14-chloro-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaen-12-one</common-name> <description>14-chloro-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaen-12-one belongs to the 1,4-benzodiazepines, a subclass of benzodiazepines within the organic compounds. It is an organoheterocyclic compound with the formula C17H14ClN5O2 and an average molecular weight of 355.80 g/mol.</description> <cas>99609-37-7</cas> <pubchem-id>3062992</pubchem-id> <chemical-formula>C17H14ClN5O2</chemical-formula> <weight>355.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-28T23:01:25Z</created-at> <updated-at type="dateTime">2026-08-28T23:01:25Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=NN=C(O1)C2=C3C4CCCN4C(=O)C5=C(N3C=N2)C=CC=C5Cl</moldb-smiles> <moldb-formula>C17H14ClN5O2</moldb-formula> <moldb-inchi>InChI=1S/C17H14ClN5O2/c1-9-20-21-16(25-9)14-15-12-6-3-7-22(12)17(24)13-10(18)4-2-5-11(13)23(15)8-19-14/h2,4-5,8,12H,3,6-7H2,1H3</moldb-inchi> <moldb-inchikey>GCMQXAVMGIOKNW-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">355.0836024</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>1.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM301344</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>14-chloro-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaen-12-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Benzodiazepines</klass> <subklass>1,4-benzodiazepines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0256537</sync-id> <structure-inchikey>GCMQXAVMGIOKNW-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>100000000000000001082000000000000000002010000000000200200000000000000002000000000001400000000000000048000000040000000020002080000008000080000000000000000800a000000000000000000000410000000000020900040000020000000000100801010040000000800000000000000000080000000080000000000000000000800100008004000000000000088002000000000000080000008000000000000000000000000000000800000000010000000010000000002000001200000000000000000080000000400040000000000000000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAZAAAAHQAAAIABBgBgAAAAAQMGQCgAAAAD BAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBAhAKAAAAAMCBkAoAAAAAwQGQCgA AAADBAYAYAAAAAMBBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBwAoAAAAAwMG ACgAAAADBAgAKAAAAAMCBkAoAAAAAwQGQCgAAAADBAdAKAAAAAMDBkBoAAAA AwMBB0AoAAAAAwMGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BBEAIAAAAAELAAEAAQJoDAIDaAwDBGgMBAVoDAQGIAYHaAwHCAAICQAJCgAK CwALDAAMDSANDigCDQ8gDxBoDBARIBESaAwSE2gMEBRoDBQVaAwVFmgMFhdo DBcYAAUBaAwTBmgMEQdoDAwIABcPaAxCBQAAAAUBAgMEBQUJCAwLCgcNDAgH ERAPBRIRBwYTBhQVFhcPEBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:14:12Z</structure-indexed-at> </compound>